Join the CCLG Global Child Cancer group webinar Tackling Drug Quality in Paediatric Oncology in Low- and Middle- Income Countries (LMIC)

Calling all Paediatric Oncologists, Nurses and Pharmacists to collaborate and make a global impact

Date: Thursday 14th May 2026
Time: 14:00-16:00 BST

Place: Online Teams meeting

Serious concerns have been raised regarding poor quality chemotherapy in several countries with which the CCLG Global Child Cancer group have partnerships. This includes asparaginase and other oncology drugs essential for treating children with cancer.

Aims of the meeting:
•Share lived experience and evidence of drug quality issues
•Discuss pharmacological, clinical and operational implications, especially procurement
•Propose actionable solutions to support partner centres
•Develop a practical roadmap for future work

Presenters:
1.Prof Girish Chinnaswamy, Tata Memorial Hospital, Mumbai, India
‘Experience from India and the National Cancer Grid. Testing of chemotherapeuticagents, biologics, PK studies, and procurement processes. Challenges in identifyingreliable manufacturers. Importance of random testing and pharmacovigilance’
2.Dr Barry Goldspiel, PharmD, President, International Society of OncologyPharmacy Practitioners (ISOPP), USA
‘The Oncology Pharmacy Society’s Perspective on Drug Quality Issues’
3.Hannah E. Sauer, PharmD, St. Jude Global Pharmacy Program, Department ofGlobal Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, USA
‘Strengthening Access to Quality Childhood Cancer Medicines: Emerging Insightsfrom a Global Platform’
4.Expert-led discussion and Q+A

Use this link to register: REGISTER NOW